Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.05
-0.08
(-1.94%)
USD |
NASDAQ |
Oct 23, 16:00
4.04
-0.01
(-0.25%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Price : 4.05 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 4.08 | 4.08 | 3.93 | 4.05 | 372925.0 |
| Oct 22, 2026 | 4.37 | 4.52 | 4.032 | 4.13 | 983758.0 |
| Oct 21, 2026 | 4.45 | 4.565 | 4.28 | 4.285 | 625935.0 |
| Oct 20, 2026 | 4.48 | 4.68 | 4.405 | 4.42 | 477643.0 |
| Oct 19, 2026 | 4.54 | 4.67 | 4.38 | 4.46 | 735788.0 |
| Oct 16, 2026 | 4.35 | 4.72 | 4.220 | 4.52 | 1.065M |
| Oct 15, 2026 | 4.40 | 4.62 | 4.23 | 4.33 | 1.090M |
| Oct 14, 2026 | 4.72 | 4.820 | 4.37 | 4.41 | 1.340M |
| Oct 13, 2026 | 5.24 | 5.26 | 4.76 | 4.78 | 654582.0 |
| Oct 12, 2026 | 5.35 | 5.402 | 5.11 | 5.27 | 1.011M |
| Oct 09, 2026 | 5.25 | 5.610 | 5.171 | 5.38 | 872798.0 |
| Oct 08, 2026 | 5.80 | 5.80 | 5.130 | 5.27 | 1.346M |
| Oct 07, 2026 | 5.72 | 5.795 | 5.47 | 5.49 | 1.242M |
| Oct 06, 2026 | 5.87 | 5.995 | 5.65 | 5.78 | 707588.0 |
| Oct 05, 2026 | 6.17 | 6.17 | 5.83 | 5.85 | 793491.0 |
| Oct 02, 2026 | 6.59 | 6.68 | 6.06 | 6.13 | 835403.0 |
| Oct 01, 2026 | 6.80 | 6.82 | 6.25 | 6.34 | 802994.0 |
| Sep 30, 2026 | 6.75 | 6.88 | 6.57 | 6.82 | 508287.0 |
| Sep 29, 2026 | 6.93 | 7.05 | 6.59 | 6.63 | 786179.0 |
| Sep 28, 2026 | 7.12 | 7.18 | 6.88 | 6.92 | 932060.0 |
| Sep 25, 2026 | 7.50 | 7.590 | 6.97 | 7.14 | 708578.0 |
| Sep 24, 2026 | 7.69 | 7.76 | 7.125 | 7.45 | 757963.0 |
| Sep 23, 2026 | 7.83 | 7.98 | 7.66 | 7.74 | 787819.0 |
| Sep 22, 2026 | 7.73 | 7.95 | 7.61 | 7.875 | 453845.0 |
| Sep 21, 2026 | 7.51 | 7.79 | 7.42 | 7.65 | 499816.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| PEG Ratio | -0.0221 |
| Price to Book Value | 0.7396 |
| Earnings Yield | -152.5% |
| Market Cap | 75.62M |
| PEGY Ratio | -0.0221 |